ADAM22 and ADAM23 modulate the targeting of the Kv1 channel-associated protein LGI1 to the axon initial segment by Hivert, Bruno et al.
HAL Id: hal-02347189
https://hal.archives-ouvertes.fr/hal-02347189
Submitted on 5 Nov 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
ADAM22 and ADAM23 modulate the targeting of the
Kv1 channel-associated protein LGI1 to the axon initial
segment
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ADAM22 and ADAM23 modulate the targeting of the Kv1
channel-associated protein LGI1 to the axon initial segment
Bruno Hivert*, Laureǹe Marien, Komlan Nassirou Agbam and Catherine Faivre-Sarrailh‡
ABSTRACT
The distribution of the voltage-gated Kv1 K+ channels at the axon
initial segment (AIS) influences neuronal intrinsic excitability. The
Kv1.1 and Kv1.2 (also known as KCNA1 and KCNA2, respectively)
subunits are associated with cell adhesion molecules (CAMs),
including Caspr2 (also known as CNTNAP2) and LGI1, which are
implicated in autoimmune and genetic neurological diseases with
seizures. In particular, mutations in the LGI1 gene cause autosomal
dominant lateral temporal lobe epilepsy (ADLTE). Here, by using rat
hippocampal neurons in culture, we showed that LGI1 is recruited to
the AIS where it colocalizes with ADAM22 and Kv1 channels.
Strikingly, the missense mutations S473L and R474Q of LGI1
identified in ADLTE prevent its association with ADAM22 and
enrichment at the AIS. Moreover, we observed that ADAM22 and
ADAM23 modulate the trafficking of LGI1, and promote its ER export
and expression at the overall neuronal cell surface. Live-cell imaging
indicated that LGI1 is co-transported in axonal vesicles with ADAM22
and ADAM23. Finally, we showed that ADAM22 and ADAM23 also
associate with Caspr2 and TAG-1 (also known as CNTN2) to be
selectively targeted to different axonal sub-regions. Hence, the
combinatorial expression of Kv1-associated CAMs may be critical to
tune intrinsic excitability in physiological and epileptogenic contexts.
KEY WORDS: Hippocampal neurons, Axonal transport, Epilepsy,
ADLTE, K+ channels
INTRODUCTION
The axon initial segment (AIS) is a unique compartment close to the
cell body that is highly enriched in voltage-gated Na+ channels and
where the action potentials are initiated. The Na+ channels are
clustered at that site by a scaffold of ankyrinG (also known as
ANK3) connected to spectrin and actin (Zhang and Rasband, 2016).
The voltage-gated Kv1 K+ channels are likewise concentrated at the
AIS, where they contribute to the control of neuronal excitability
(Kole and Stuart, 2012; Rasband, 2010; Vacher and Trimmer,
2012). Kv1 channels co-purify with several cell adhesion molecules
(CAMs) including Caspr2 (also known as CNTNAP2) and leucine-
rich glioma inactivated 1 (LGI1), which may influence their
positioning within the distinct axonal sub-regions. The importance
of these CAMs in neuronal function is reflected by their implicated
role in both genetic and autoimmune diseases associated with
hyperexcitability and epilepsy (Kegel et al., 2012; Lai et al., 2010;
Muona et al., 2016; Ohkawa et al., 2013; Rodenas-Cuadrado et al.,
2014). Antibody-mediated limbic encephalitis, which was first
associated with Kv1 channels, has been mainly attributed to
autoantibody binding to Caspr2 or LGI1 (Irani et al., 2010;
Lancaster et al., 2011). Caspr2 is associated with TAG-1 (also known
as CNTN2) at the juxtaparanodes of myelinated axons, where it
mediates axo-glial contacts and induces the clustering of Kv1
channels to control the internodal resting potential (Poliak et al.,
2003; Traka et al., 2003). In addition to juxtaparanodes, Caspr2 and
TAG-1 are concentrated at the AIS of cortical and motor neurons,
but they are not required for the recruitment of Kv1 channels at that
site (Duflocq et al., 2011; Inda et al., 2006; Ogawa et al., 2008). In
cultured hippocampal neurons, Kv1 channels are enriched at the
AIS associated with TAG-1, whereas Caspr2 is targeted all along
the axon (Pinatel et al., 2017). Other membrane proteins interacting
with Kv1 channels may be localized at the AIS, including
ADAM22, which is recruited at the AIS of cultured hippocampal
neurons with PSD93 (also known as DLG2) (Ogawa et al., 2010).
However, the precise mechanisms implicated in the recruitment of
the Kv1 complex at the AIS are still elusive (Rasband, 2010).
Actually, the polarized distribution of ion channels and CAMs
at the somato-dendritic or axonal compartments may depend on
several cellular mechanisms, including their sorting in distinct
transport vesicles associated with specific kinesin motors, selective
internalisation by endocytosis and diffusion/trapping in the cell
membrane (Lasiecka et al., 2009). In particular, the AIS is a zone
of restricted diffusion for the lateral mobility of transmembrane
proteins, which are anchored to the ankyrin–spectrin–actin
cytoskeleton. We previously reported that the Kv1-associated
molecules TAG-1 and Caspr2 are co-transported in axonal
vesicles whereas they are differently distributed along the axon
(Bel et al., 2009; Pinatel et al., 2017). In the present study, we
examined the role of ADAM proteins in the vesicular transport of
distinct Kv1-associated CAMs, including TAG-1, Caspr2 and LGI1
and whether their interplay contributes to their targeting at the AIS.
LGI1 is a secreted glycoprotein consisting of leucine-rich and
epitempin (EPTP) repeats that has been implicated in protein–
protein interactions at the synapse, but was not described at the AIS
until recently (Seagar et al., 2017). LGI1 interacts, via its EPTP
repeats, with members of the ADAM family, including ADAM11,
ADAM22 and ADAM23 (Fukata et al., 2006; Owuor et al., 2009;
Sagane et al., 2008). LGI1 has been proposed to form a transynaptic
complex with ADAM22 and ADAM23 controlling synaptic
strength at excitatory synapses by regulating PSD95 (also known
as DLG4) incorporation (Fukata et al., 2010; Lovero et al., 2015).
LGI1 at the pre-synaptic terminals has been reported to act as a
negative modulator of glutamate release, an effect which could be
linked with pre-synaptic Kv1 channels (Boillot et al., 2016). In
patients with autoimmune encephalitis, anti-LGI1 antibodies may
disrupt its interaction with ADAM proteins (Ohkawa et al., 2013).Received 2 May 2018; Accepted 19 December 2018
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Furthermore, LGI1 is a monogenic human epilepsy-related gene
mutated in autosomal dominant lateral temporal lobe epilepsy
(ADLTE) (Gu et al., 2002; Kalachikov et al., 2002; Kegel et al.,
2012; Morante-Redolat et al., 2002). LGI1 needs to be glycosylated
in order to be secreted, and most ADLTE mutations inhibit LGI1
secretion by preventing its proper folding. Interestingly, some
mutations do not inhibit secretion but were found to impair
interactions with ADAM22 and ADAM23 (Dazzo et al., 2016;
Yokoi et al., 2015).
Our present data indicate that LGI1 is enriched at the AIS where it
colocalizes with ADAM22 and Kv1 channels in cultured
hippocampal neurons. The ADAM proteins modulate the
vesicular trafficking of LGI1, and promote its ER export and
axonal transport leading to increased expression at the overall cell
surface. In addition, we show that ADAM22 is critical for the
enrichment of LGI1 at the AIS. Importantly, the secreted missense
mutants LGI1S473L and LGI1R474Q identified in ADLTE display
altered association with ADAM22 and are not properly targeted to
the AIS. These mutations may induce perturbation of the LGI1
function in tuning intrinsic excitability, thus contributing to
epileptogenesis.
RESULTS
LGI1 is targeted at the AIS of cultured hippocampal neurons
The Kv1 channels are known to associate with several membrane
proteins, including ADAM22, ADAM23 and LGI1 at the
presynaptic terminals. LGI1 was recently reported to be enriched
at the AIS of hippocampal CA3 neurons in immunofluorescence
staining studies on brain sections (Seagar et al., 2017). Here, we
examined whether these CAMs may also interplay with the Kv1
complex at the AIS of hippocampal neurons in culture. In
hippocampal neurons at DIV8 (day in vitro 8), we showed that
LGI1 was faintly expressed at the AIS surface by live
immunostaining with an anti-LGI1 monoclonal antibody (mAb)
(Fig. 1A, green), and colocalized with the AIS marker ankyrinG
(Fig. 1A, blue). In contrast, at DIV21 when the synaptic network is
established, LGI1 was present as small clusters on the somato-
dendritic compartment (Fig. 1B), and colocalized with the synaptic
marker synaptobrevin (Fig. 1E, red). We observed that ADAM22
(Fig. 1C), but not ADAM23 (Fig. 1D), was enriched at the AIS by
performing immunostaining after fixation and permeabilization, as
described by Ogawa et al. (2010).
We next analyzed the subcellular distribution of LGI1–GFP
transfected in hippocampal neurons. We observed that LGI1–GFP
was highly restricted at the AIS surface when transfected at DIV7
and visualized at DIV8 using live immunostaining with anti-GFP
antibody (Fig. 1F, red). The direct fluorescence of intracellular
LGI1–GFP was faintly detected (Fig. 1F, green) and we decided for
the next series of experiments to perform live immunostaining for
GFP using Alexa Fluor 488 (green)-conjugated secondary
antibodies. Surface LGI1–GFP (green) strongly colocalized with
endogenous ADAM22 enriched at the AIS (blue), suggesting that
the two proteins may be associated at that site (Fig. 1G).
ADAM22 and ADAM23 modulate LGI1 targeting at the AIS
of hippocampal neurons
Strikingly, co-transfection with ADAM22 or ADAM23 at DIV7
strongly increased the somato-dendritic and axonal compartment
cell surface expression of LGI1–GFP 1 day later (Fig. 2A,B, green;
C, red). Indeed LGI1–GFP expressed alone displayed a fluorescence
intensity AIS:axon ratio of 3.26±0.23 (n=16; mean±s.e.m.). This
ratio was significantly reduced to 1.38±0.11 (n=24) and 1.15±0.10
(n=19) when co-transfected with ADAM22 and ADAM23,
respectively (Fig. 2F). As a control experiment, we examined the
polarized distribution of NrCAM–GFP since NrCAM does not
belong to the Kv1 complex and is strongly recruited to the AIS by its
ankyrinG-binding motif (Davis et al., 1996). NrCAM–GFP
displayed an AIS:axon ratio of 4.05±0.6 (n=20) and 5.51±0.9
(n=15) in the absence or presence of ADAM22, respectively
(Fig. 2F). Therefore, the co-expression of ADAM22 did not modify
the AIS distribution of NrCAM as illustrated in Fig. 2D,E.
Next, the ADAM23 sequence was fused to mCherry at its
C-terminal to facilitate its fluorescent detection (red) and it
was surface labeled using a rabbit anti-ADAM23 antibody
(green) (Fig. S1B). ADAM23–mCherry exhibited a non-polarized
surface expression when transfected alone (Fig. S1B) or when co-
transfected with LGI1–GFP (Fig. S1C). It displayed an AIS:axon
ratio of 1.58±0.13 (n=11) (Fig. S1D). Moreover, LGI1–GFP
colocalized with ADAM23–mCherry in clusters both along
dendrites (Fig. S1C′) and the axon, as identified via ankyrinG
labeling (Fig. S1C″), in contrast with its AIS-restricted distribution
when transfected alone (Fig. S1A).
We asked whether the recruitment of LGI1–GFP to the AIS may
be correlated with the concentration of Kv1 channels at the AIS. In
contrast to the early appearance of ankyrinG, NrCAM and voltage-
gated Na+ channels, the Kv1.1 and Kv1.2 subunits (also known as
KCNA1 and KCNA2, respectively) are tethered at the AIS of
cultured hippocampal neurons only after 10 days in vitro (Sánchez-
Ponce et al., 2012; Vacher and Trimmer, 2012; Vacher et al., 2011).
We analyzed neurons transfected with LGI1–GFP or co-transfected
with LGI1–GFP and ADAM23–mCherry at DIV13, and the
expression of endogenous Kv1.2 was measured at the AIS and
along the axon 1 day later (Fig. 2G–J). When LGI1–GFP was
transfected alone, it was enriched at the AIS and colocalized with
Kv1.2 (Fig. 2G). The ratio of the mean fluorescence intensity at the
AIS versus the axon was 2.82±0.3 for LGI1–GFP and 2.47±0.24 for
Kv1.2. Individual values (n=13) were plotted, showing that the AIS:
axon ratio for LGI1–GFP could be correlated with that for the Kv1.2
channels (Fig. 2I). In contrast, when expressed with ADAM23–
mCherry, LGI1–GFP was no longer enriched at the AIS of
co-transfected neurons (Fig. 2H,J). Therefore, the interplay
between ADAM proteins and LGI1 may contribute to modulate
the composition of the Kv1 complex at the AIS.
Our data indicate that the ADAM proteins may increase LGI1–
GFP expression at the overall neuronal cell surface either by
stabilizing the secreted glycoprotein at the cell membrane or by
promoting its export along the secretory pathway. In addition,
overexpression of ADAM proteins may reduce anchoring of LGI–
GFP at the AIS through competition with endogenous ADAM22
enriched at this axonal subdomain.
ADAM22 and ADAM23 promote ER export of LGI1
We analyzed whether the ADAM proteins could be involved in the
intracellular trafficking of LGI1 in transfected HEK cells. We
observed that LGI1–GFP was strongly retained in the ER (green)
when transfected alone in HEK cells and was poorly detected at the
cell surface in live immunolabeling experiments for GFP and Alexa
Fluor 647-conjugated secondary antibody (blue) (Fig. 3A). In
contrast, LGI1–GFP co-expressed with ADAM23–mCherry was
faintly detected in the ER and as strongly labeled clusters at the cell
surface (blue) (Fig. 3C). When co-transfected with ADAM22–
mCherry, LGI1–GFP was also detected at the cell surface (Fig. 3B).
Thus, we hypothesized that the association with ADAM proteins
may favor the ER exit of LGI1.
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We examined the N-glycosylation processing of LGI1-GFP when
expressed alone or in association with ADAM22 or ADAM23 in
HEK cells. We analyzed the glycosylation pattern of LGI1–GFP
by undertaking an experiments with endoglycanase H (Endo H),
which digests only immature ER-type high-mannose N-glycans.
N-glycosidase F (PNGase F) was used to remove all the N-glycans.
LGI1–GFP contained Endo H-sensitive carbohydrates when
transfected alone (Fig. 3G). In contrast, when co-transfected with
ADAM22 or ADAM23, two bands of LGI1–GFP were detected
after treatment with Endo H, the higher band being Endo H-resistant
and the lower band Endo H-sensitive form (Fig. 3G). This result
indicates that ADAM22 and ADAM23 favor ER exit of LGI1, likely
by acting as chaperone-like proteins through the ER quality-control
system in HEK cells. In accordance with the results of Yokoi et al.
(2015), we observed that Endo H digestion produced amobility shift
of LGI1–GFP while PNGase F treatment induced a further mobility
shift of the same pool, as an indication that LGI1 can be partially
processed in the absence of ADAM proteins.
The secreted mutants LGI1S473L and LGI1R474Q are not
targeted to the AIS and display reduced interaction with
ADAM22
Human epilepsy-related missense mutations of LGI1 have been
reported and classified as secretion-defective or secretion-
competent mutations. Among this last category, LGI1S473L, which
is mutated in the EPTP domain, displays a reduced ability to bind to
Fig. 1. LGI1 is enriched at the AIS in cultured hippocampal neurons. (A,B,E) Hippocampal neurons at DIV8 orDIV21were surface labeled using anti-LGI1mAb
(green), and fixed and permeabilized before immunostaining for ankyrinG (A,B, blue) as a marker of the AIS (arrowheads) and MAP2, as a dendritic marker (A,B,
red), or synaptobrevin (E, red), as a presynaptic marker, and MAP2 (E, blue). Note that endogenous LGI1 is only detected at the AIS at DIV8, whereas it is mainly
distributed as puncta on the somato-dendritic compartment at DIV21. Arrows in E point to presynaptic terminals double-labeled for LGI1 and synaptobrevin. (C,D)
DIV8 hippocampal neurons were fixed and permeabilized before immunostaining for ADAM22 (C) or ADAM23 (D), ankyrinG (blue) and MAP2 (red). Only ADAM22
is detected at the AIS (arrowheads), where it colocalized with ankyrinG. (F) Hippocampal neurons transfected at DIV7 with LGI1–GFP and immunostained at
DIV8. Surface immunostaining of GFP using Alexa-Fluor-568-conjugated secondary antibodies (red) with direct imaging of LGI1–GFP fluorescence (green). LGI1–
GFP surface labeling is restricted to the AIS, labeled with ankyrinG (blue). (G) Hippocampal neurons transfected at DIV7 with LGI1–GFP and mCherry. LGI1–GFP
surface labeling (green) is colocalized at the AIS with endogenous ADAM22 (blue) immunostained after fixation and permeabilization. The AIS is indicated with
yellow arrowheads. Scale bar: 20 µm. The diagram summarizes the markers used to identify the different neuronal compartments.
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ADAM22 but not ADAM23 (Yokoi et al., 2015). Therefore, we
asked whether LGI1S473L could be properly targeted to the AIS of
hippocampal neurons when expressed alone or in combination with
ADAM22 or ADAM23. First, we analyzed the processing of
LGI1S473L in HEK cells and observed that both ADAM22 and
ADAM23 induced its cell surface expression (Fig. 3D–F). Western
blotting experiments indicated that LGI1S473L displayed Endo
H-sensitive N-glycans when expressed alone in HEK cells, showing
Fig. 2. Co-expression of ADAM22 or ADAM23 modulates the targeting of LGI1 at the AIS in hippocampal neurons. (A–F) Hippocampal neurons were
transfected at DIV7 with LGI1–GFP and ADAM22 (A) or ADAM23 (B,C), NrCAM (D), or NrCAM and ADAM22 (E). Neurons were surface labeled 1 day later using
anti-GFPantibodies (A,B,D,E, green; C, red), and fixed and permeabilized before immunostaining for ankyrinG (blue, arrowheads). Co-transfection with ADAM22
(A) or ADAM23 (B,C) strongly enhances LGI1–GFP expression at the somato-dendritic and axonal surface. Co-transfection with ADAM22 has no effect on
NrCAM distribution at the AIS (D,E). (F) Ratios of fluorescence intensity between the AIS and axon in neurons transfected at DIV7 with LGI1–GFPalone, NrCAM–
GFP alone, or co-transfected with ADAM22 (A22) or ADAM23 (A23). Results are mean±s.e.m., n=15–24. * indicates significant differences by comparison with
LGI1–GFP transfected alone for co-transfection with ADAM22 or ADAM23 [F(2, 56)=55.68, ANOVA and P<0.01, Fisher test]. The co-expression of ADAM22 did
not modify the AIS distribution of NrCAM-GFP (Mann–Whitney test, P=0.13). (G–J) The AIS enrichment in LGI1–GFP correlated with AIS expression of
endogenous Kv1.2. DIV13 hippocampal neurons were transfected with LGI1–GFP (G) or with LGI1–GFP and ADAM23–mCherry (H). Neurons were surface
labeled 1 day later for GFP (green), and fixed, permeabilized and immunostained for Kv1.2 (blue). Note that LGI1–GFP is strongly colocalized with Kv1.2 at the
AIS in a neuron transfected with LGI1–GFP alone, but not in a neuron co-transfected with LGI1–GFP and ADAM23–mCherry. The AIS is indicated with an
arrowhead. (I,J) The AIS:axon ratios of fluorescence intensity for LGI1–GFP and Kv1.2 were plotted for individual neurons when transfected with LGI1–GFP or
co-transfected with LGI1–GFP and ADAM23-mCherry. Scale bar: 20 µm (main images), 5 µm (magnifications).
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the same mobility shift as the wild-type LGI1–GFP after Endo H or
PNGase F treatment (Fig. 3H). LGI1S473L co-expressed with
ADAM22 or ADAM23 displayed both Endo H-resistant and Endo
H-sensitive glycoforms (Fig. 3H). Thus, LGI1S473L still had the
capacity of interacting in cis with ADAM proteins, which enhanced
its ER exit and processing with complex N-glycans in HEK cells.
Strikingly, when transfected in hippocampal neurons at DIV7,
LGI1S473L was not enriched at the AIS (Fig. 4C) in contrast to
wild-type LGI1–GFP (Fig. 4A). The mean AIS:axon ratios were
3.62±0.39 (n=20) for LGI1–GFP and 1.18±0.09 (n=17) for
LGI1S473L. Co-transfection with ADAM22– or ADAM23–
mCherry strongly enhanced the surface labeling of LGI1S473L,
which became unpolarized at the neuronal cell surface (Fig. 4G,H).
These data indicate that the binding activity of LGI1S473L for
ADAM22 and ADAM23 allows its transport to the cell surface in
hippocampal neurons. Next, we tested the distribution of two other
secreted mutants of LGI1, LGI1R407C and LGI1R474Q when
transfected in DIV7 hippocampal neurons. As expected, the
R474Q mutation, which is adjacent to the S473L mutation also
prevented the AIS enrichment of LGI1 (Fig. 4D,J). In contrast,
LGI1R407C was enriched at the AIS of hippocampal neurons as
observed for the wild-type LGI1 (Fig. 4B,J). The mean AIS:axon
ratios were 1.55±0.13 (n=17) for LGI1R474Q and 2.72±0.19 (n=19)
for LGI1R407C. Co-transfection with ADAM22– or ADAM23–
mCherry strongly enhanced the neuronal cell surface expression
of LGI1R474Q (data not shown) and LGI1R407C (Fig. 4E,F). In
Fig. 3. ADAM proteins promote ER exit and N-glycan
maturation of LGI1 and LGI1S473L and differentially
associate with LGI1 mutants. HEK cells (A–F) were
transfected with LGI1–GFP alone (A), or co-transfected with
ADAM22– (B) or ADAM23–mCherry (C), transfected with
LGI1S473L–GFP alone (D), or co-transfected with ADAM22– (E)
or ADAM23–mCherry (F). The fluorescence for GFP was
directly imaged (green) to visualize the intracellular pool of LGI1
whereas the surface pool was labeled using anti-GFP antibody
(blue). Note that ADAM22 and ADAM23 promote ER exit and
surface expression of LGI1 and LGI1S473L. Scale bar: 10 µm.
(G,H) HEK cells were transfected with LGI1–GFP (G) or
LGI1S473L–GFP (H) alone or co-transfected with ADAM22–
mCherry or ADAM23–mCherry. After cell lysis, wild-type or
mutated LGI1 was immunoprecipitated using anti-GFP mAb
and incubated at 37°C for 3 h without (−) or with Endo H
(denoted with an H) or PNGase F (denoted with an F). Western
blotting with anti-GFPmAb shows that LGI1–GFPmigrates as a
doublet when co-transfected with ADAM22 or ADAM23 and
incubated with Endo H. Note that the lower band corresponding
to the EndoH-sensitive glycoformmigrates in the same position
as LGI1–GFP treated with PNGase F. The higher band, which
is Endo H-resistant, migrated in the same position as untreated
LGI1-GFP. The LGI1S473L mutant also displayed Endo
H-sensitive and resistant glycoforms. (I,J) HEK cells were
transfected with LGI1–GFP (lane 1) or ADAM23–mCherry
(lane 2) alone, or co-transfected with GFP-tagged LGI1,
LGI1R407C, LGI1S473L or LGI1R474Q and ADAM22–mCherry
or ADAM23–mCherry. After cell lysis, ADAM proteins were
immunoprecipitated using rabbit anti-mCherry.Western blotting
was performed using rabbit anti-mCherry (I) and anti-GFP
antibodies (J) to reveal co-immunoprecipitated proteins.
Experiments were performed in triplicate. (K) Quantitative
analysis of co-immunoprecipitated and immunoprecipitated
proteins was performed using the ImageJ software and
expressed as a percentage of the wild-type LGI1 value. Results
are mean±s.e.m., n=3. * indicates significant differences of the
ratio of co-precipitated LGI1 mutant relative to the amount of
immunoprecipitated ADAM22 by comparison with wild-type
LGI1 using ANOVA (P<0.021) and t-test (P=0.0011 and
P=0.0135 for LGI1S473L or LGI1R474Q, respectively).
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conclusion, two missense mutations located in the EPTP6 domain,
the S473L and R474Q mutations, both impair the recruitment of
LGI1 to the AIS as a possible pathogenic mechanism. In contrast,
the mutation R407C in the EPTP4 domain had no effect on AIS
targeting (Fig. 4I).
The association of the three LGI1 mutants with co-transfected
ADAM22 and ADAM23 is sufficient to promote their expression
at the neuronal cell surface. However, an altered interaction with
ADAM22, which is anchored at the AIS of hippocampal neurons,
may prevent their proper targeting at that site. Using
co-immunoprecipitation experiments from transfected HEK cells,
we analyzed the association of the secreted LGI1 mutants
LGI1R407C, LGI1S473L and LGI1R474Q with ADAM22– or
ADAM23–mCherry (Fig. 3I,J). Single transfections with
LGI1–GFP or ADAM23–mCherry were used as negative
controls. All the secreted mutants were co-immunoprecipitated
with ADAM23–mCherry as was the case for the wild-type LGI1–
GFP (Fig. 3J, left panel, K). However, the S473L and R474Q
mutations significantly reduced the co-immunoprecipitation of
LGI1 with ADAM22–mCherry (Fig. 3J, right panel, K). These
results suggest that these missense mutations may impair the
anchorage of LGI1 to ADAM22 at the AIS of hippocampal neurons.
To investigate whether ADAM22 may be implicated in trapping
LGI1 at the AIS, we tested the effect of ADAM22 depletion using
siRNA transfection. Hippocampal neurons were transfected at
DIV7 with LGI1–GFP and control, ADAM23-, or ADAM22-
specific siRNAs and analyzed 4 days later via immunofluorescence
staining (Fig. 5). We observed that the amount of ADAM22 was
Fig. 4. The variants of LGI1 associated with epilepsy are differentially recruited at the AIS of hippocampal neurons. DIV7 hippocampal neurons were
transfected with GFP-tagged LGI1 (A), LGI1R407C (B), LGI1S473L (C) and LGI1R474Q (D). Note that both LGI1S473L and LGI1R474Q are not enriched at the AIS
in contrast to wild-type LGI1 and LGI1R407C. GFP-tagged LGI1R407C or LGI1S473L were co-transfected with ADAM22– (E,G) or ADAM23–mCherry (F,H). When
co-transfected with ADAM22– or ADAM23–mCherry, the neuronal surface expression of all the variants is strongly increased. (I) Schematic representation of
LGI1 with the point mutations localized in the EPTP domains. LRR, leucine-rich repeats; LRRNT, N-terminal LRR; LRRCT, C-terminal LRR. (J) Ratios
of fluorescence intensity between AIS and axon in neurons transfected at DIV8 with GFP-tagged LGI1, LGI1R407C, LGI1S473L or LGI1R474Q. Results are
mean±s.e.m., n=17–20. * indicates significant differences by comparison with wild-type LGI1–GFP (P<0.0001, Mann–Whitney test). Scale bar: 20 µm.
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significantly decreased, by 30–37%, at the AIS of neurons
transfected with two different ADAM22-specific siRNAs
(s186484 and s186485) by comparison with non-transfected
neurons in the same areas (Fig. 5B,C,E). Strikingly, LGI1–GFP
immunofluorescence intensity at the AIS was almost completely
abolished (78–85% reduction) in neurons transfected with
ADAM22 siRNAs by comparison with neurons transfected with
control or ADAM23-specific siRNAs (Fig. 5F). Taken together,
these results indicate that ADAM22 is critical for the enrichment of
LGI1–GFP at the AIS.
Axonal transport of ADAM22, ADAM23 and LGI1
We next investigated whether LGI1 could be associated with
ADAM proteins in axonal transport vesicles. First, we performed
time-lapse imaging of neurons transfected at DIV7 with ADAM22–
mCherry or ADAM23–mCherry to get insights into their axonal
Fig. 5. siRNA-mediated silencing of ADAM22 prevents the expression of LGI1–GFP at the AIS of hippocampal neurons. Hippocampal neurons were
transfected at DIV7 with LGI1–GFP, mCherry and control- (A), ADAM22 (B,C) or ADAM23 siRNAs (D). Cells were surface labeled at DIV11 using anti-GFP
antibody (Alexa Fluor 488, green), and fixed and permeabilized before immunostaining for ADAM22 (Alexa Fluor 647, blue) and ankyrinG (Alexa Fluor 405,
white). LGI1–GFP is highly recruited at the AIS of neurons transfected with control (A) or ADAM23 siRNA (D), whereas it is hardly detectable in the presence
of ADAM22 siRNAs (B,C). Note that ADAM22 is still detected at the AIS in cells transfected with ADAM22 siRNAs (B,C), but with a lower fluorescence
intensity than in the untransfected neurons. Red and white arrowheads indicate the AIS of transfected and untransfected neurons, respectively. Scale bar: 20 µm.
(E)Mean±s.e.m. fluorescence intensity for ankyrinG andADAM22 at the AIS of transfected neurons as a percentage of the value for 2–3 untransfected neurons in
the same areas (11–15 areaswere imaged using identical confocal parameters under each condition). *P=0.0251, **P=0.0086 by comparison with control siRNA
(Mann–Whitney test). (F) Mean±s.e.m. (n=11–15) fluorescence intensity for LGI1–GFP at the AIS of transfected neurons as a percentage of the value for control
siRNA. ***P<0.0001 by comparison with control siRNA [F(3,45)=16.03, ANOVA].
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targeting mechanisms. The axon was clearly identified on the basis
of its length (and was strongly enriched in transport vesicles by
comparison with dendrites). In addition, live immunolabeling of
neurofascin isoform 186 (NF186) was used to precisely localize the
AIS after time-lapse recording (Fig. 6A,B, blue). In neurons that
were transfected with ADAM22–mCherry, we observed that
labeled vesicles were axonally transported in the anterograde and
retrograde directions with a maximal velocity (Vm) of 0.69±0.1 and
0.51±0.06 µm s−1, respectively (Table S1; Movie 1). In ADAM23–
mCherry-transfected neurons, labeled vesicles were transported in
the anterograde and retrograde directions with a Vm of 0.99±0.11
and 0.53±0.06 µm s−1, respectively (Table S1; Movie 2). However,
ADAM22 vesicles moved bi-directionally in most neurons
(Table S1, n=10 neurons) whereas, by contrast, ADAM23
vesicles were mostly transported in the anterograde direction
(65.2±9.5% of displacements, n=9 neurons; mean±s.e.m.) as
indicated by kymograph analysis (Fig. 6A′,B′).
Next, we performed two-color time-lapse imaging of neurons
co-transfected with ADAM23–mCherry and LGI1–GFP to
visualize their axonal transport (Fig. 6C–E). We found that most
of the axonal transport vesicles were colabeled for LGI1 and
ADAM23. Kymograph analysis of transport events indicated that
Fig. 6. LGI1 and ADAM23 are
colocalized in transport vesicles.
(A,B) Hippocampal neurons were
transfected at DIV7 with ADAM22–
mCherry (A) or ADAM23–mCherry (B).
Time-lapse images of axonal transport
vesicles were acquired 1 day later at 1
frame per 1.5 s. Live immunostaining
with Alexa Fluor 647-coupled anti-
Neurofascin186 was performed to
determine AIS location (blue) limited
with blue arrowheads. (A′,B′)
Corresponding kymographs with axonal
length in x-axis and time in y-axis.
Anterograde and retrograde events are
highlighted with green and orange
traces, respectively. The maximal
velocity was measured for each
transport sequence. Note that transport
events were mostly in the retrograde
direction for ADAM22 whereas they
were mostly in the anterograde direction
for ADAM23. See the corresponding
Movies 1 and 2. (C–E) Hippocampal
neurons were co-transfected with LGI1–
GFP and ADAM23–mCherry at DIV8.
Live-cell recording of proximal (C) and
distal (D,E) axons. The orange
arrowhead labels a proximal axon
bifurcation in C,C′. (C′,D′) The
corresponding kymographs show
overlapping trajectories of vesicles
labeled for LGI1–GFP and ADAM23–
mCherry. Comparison of traces for
transport events along the axon indicated
that a number of vesicles were colabeled
with LGI1–GFP and ADAM23–mCherry
moving both in anterograde and
retrograde directions. (E) Time-lapse
sequence showing a moving vesicle
that contains both LGI1–GFP and
ADAM23–mCherry, indicated with
arrows. Movies 3 and 4 show time-lapse
recordings of proximal and distal axons,
respectively. Scale bars: 20 µm.
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double-labeled vesicles moved bi-directionally, as illustrated in
proximal (Fig. 6C,C′) or distal (Fig. 6D,E) axonal regions (Movies 3
and 4). The Vm for the anterograde and retrograde transports was
0.87±0.09 and 0.86±0.08 µm s−1, respectively. We observed mostly
anterograde events (74±4.7% of displacements, n=4 neurons), as
occurring in neurons transfected with ADAM23 alone. In neurons
co-transfected with ADAM22–mCherry and LGI1–GFP, we also
observed axonal vesicles colabeled for both CAMs that were mostly
retrogradely transported (Fig. S2, n=3 neurons). Vesicles labeled for
LGI1–GFP were not easily detected when transfected alone, further
indicating that LGI1 may require co-expression with ADAM22 or
ADAM23 for its proper trafficking and axonal transport.
Biochemical interactions of ADAM22 and ADAM23 with the
Kv1-associated CAMs TAG-1 and Caspr2
Apart from LGI1 and ADAM proteins, another set of CAMs,
including TAG-1 and Caspr2, has been reported to associate with
Kv1 channels at discrete regions of the axon, and we investigated
whether these different CAMs may interact in complex with the
ADAM22 and ADAM23 proteins. Biochemical interactions
between LGI1 and both ADAM22 and ADAM23 have been well
documented; LGI1 interacts, via its EPTP repeats, with several
members of the ADAM family, including ADAM22 and ADAM23,
as reported using cell-binding assays and co-immunoprecipitation
experiments (Fukata et al., 2006; Owuor et al., 2009; Sagane et al.,
2008). Hence, we performed co-imunoprecipitation experiments
from transfected HEK cells to investigate whether ADAM22 and
ADAM23 could also interact with TAG-1 and Caspr2. As shown in
Fig. 7A,C, using co-immunoprecipitation with anti-mCherry or
anti-GFP antibodies, LGI1–GFP but not TAG-1–GFP could form a
complex with ADAM23–mCherry. In addition, we showed that
HA-tagged Caspr2 and Caspr2–GFP were co-immunoprecipitated
with ADAM23–mCherry when using an anti-mCherry antibody
(Fig. 7B,C). Moreover, Caspr2 with a deleted cytoplasmic tail
(Caspr2Δcyt) was also efficiently co-immunoprecipitated with
ADAM23, demonstrating that these membrane proteins interact
via their ectodomains or transmembrane domains (Fig. 7B).
Conversely, ADAM23 was not precipitated with HA-tagged
Caspr2 when using anti-HA antibody (Fig. 7B). We note that
mCherry is fused at the C-terminus of ADAM23 cytoplasmic
tail whereas HA is placed at the N-terminal region of Caspr2, so that
it is possible that the anti-HA antibody could interfere with the
Fig. 7. Biochemical analysis of the interaction between ADAM proteins and LGI1, TAG-1 or Caspr2. Co-immunoprecipitation experiments from
HEK cells transfected with ADAM23–mCherry (A–C) or ADAM22–mCherry (D–F), and TAG-1–GFP or LGI1–GFP (A,D), or Caspr2-HA constructs, either full-
length (C2) or deleted from the cytoplasmic tail (Δcyt) (B,E), Caspr2–GFP (C) or NrCAM–GFP (Nr) (F). Immunoprecipitation of ADAM22– or ADAM23–mCherry
was performed using rabbit anti-mCherry antibody (IP mCh). Immunoprecipitation of TAG-1–GFP, Caspr2–GFP or LGI1–-GFP was performed with mouse
anti-GFP mAb (IP GFP). After western blotting, TAG-1, LGI1, Caspr2 and NrCAM constructs were detected using mouse anti-GFP mAb, ADAM proteins
using rabbit anti-mCherry antibody, and Caspr2–HA constructs using rat anti-HA mAb in the lysates (input) and immunoprecipitates. LGI1–GFP was
co-immunoprecipitated with ADAM22 (D) and ADAM23 (A). TAG-1 was co-immunoprecipitated with ADAM22 (D) but not with ADAM23 (A). Both full-length
Caspr2 and Caspr2 Δcyt were co-immunoprecipitated with ADAM22 (E) and ADAM23 (B,C). Reciprocally, ADAM23 was not detected after immunoprecipitation
of Caspr2 using anti-HA mAb (B). NrCAM was not co-immunoprecipitated with ADAM22 (F). Experiments were performed in triplicate.
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binding between CAM ectodomains. In addition, we also showed
that LGI1–GFP and TAG-1–GFP were co-immunoprecipitated
with ADAM22-mCherry (Fig. 7D). Caspr2 and Caspr2Δcyt were
similarly co-immunoprecipitated with ADAM22–mCherry when
using an anti-mCherry antibody (Fig. 7E). By contrast, NrCAM–
GFP did not associate with ADAM22–mCherry (Fig. 7F) or
ADAM23–mCherry (data not shown). Thus, when expressed in
HEK cells, ADAM22 and ADAM23 display the capability
to selectively associate with multiple CAMs related to the
Kv1 complex.
The axonal targeting of ADAM23 is modulated by its
co-expression with TAG-1 and Caspr2
We asked whether the ADAM proteins could interfere with the
axonal targeting of the two components of the Kv1 complex, Caspr2
and TAG-1. We recently showed that both endogenous and
transfected TAG-1 and Caspr2 are differentially distributed in
cultured hippocampal neurons; TAG-1 is enriched at the AIS
whereas Caspr2 is evenly localized along the axon (Pinatel et al.,
2017). Neurons were co-transfected at DIV13 with TAG-1–GFP
and ADAM23, and surface labeled using anti-GFP and anti-
ADAM23 antibodies 1 day later. Strikingly, we observed that
ADAM23 colocalized with TAG-1 at the neuronal surface and was
enriched at the AIS (Fig. S3A). In contrast, ADAM23 was faintly
detected along the axonal surface when co-transfected with Caspr2–
HA (Fig. S3B). Since Caspr2 is strongly internalized in the somato-
dendritic compartment (Bel et al., 2009), we analyzed whether
ADAM23 could be associated with Caspr2 in endocytic vesicles.
Immunoendocytosis of Caspr2 was induced using anti-HA mAb
and we observed that, indeed ADAM23 was colocalized with
Caspr2 in intracellular vesicles labeled for the early endosome
marker EEA1 (Fig. S3C). Next, neurons were co-transfected with
TAG-1–GFP or Caspr2–HA together with ADAM23-mCherry to
better visualize ADAM23 and perform quantitative analysis. The
direct fluorescence of ADAM23–mCherry was strongly detected
at the AIS in DIV14 hippocampal neurons, when co-expressed
with TAG-1–GFP (Fig. 8A), but not with Caspr2–HA (Fig. 8B).
The AIS:axon ratio of ADAM23–mCherry expressed alone or
co-transfected with Caspr2 was 1.5±0.1 (n=9) and 1.3±0.1 (n=16),
respectively. ADAM23 was significantly enriched at the AIS when
co-transfected with TAG-1, with an AIS:axon ratio of 2.0±0.2
(n=11) (Fig. 8C).
Through time-lapse live-cell imaging, we analyzed whether
TAG-1, Caspr2 and ADAM23 were sorted within the same axonal
transport vesicles (Fig. S4). We observed vesicles colabeled with
ADAM23–mCherry and TAG-1–GFP moving along the axon
(Fig. S4A–E; Movies 5 and 6). Kymograph analysis of transport
events indicated that these vesicles moved in the anterograde and
Fig. 8. ADAM23–mCherry is co-targeted with
TAG-1–GFP to the AIS of hippocampal neurons.
Hippocampal neurons were co-transfected at
DIV13 with ADAM23–mCherry and TAG-1–GFP
(A), or with Caspr2–HA and ADAM23–mCherry
(B,C). Neurons were surface labeled with mouse
anti-GFP mAb (A, green) or rat anti-HA (B, green)
antibodies and the fluorescence of ADAM23–
mCherry was directly imaged (red). Cells were fixed
and permeabilized before immunostaining for
ankyrinG (blue, arrowheads). Note that ADAM23–
mCherry was enriched and colocalized with TAG-1
at the AIS (A, magnification) whereas it was faintly
detected at the AIS when co-transfected with
Caspr2–HA (B). (C) Ratios of mean±s.e.m. (n=9–
16) fluorescence intensity between the AIS and
axon for TAG-1–GFP, ADAM23–mCherry (A23)
and Caspr2 (C2), either transfected alone or co-
transfected. *P<0.01 (non-parametric Mann–
Whitney test). Scale bars: 20 μm (main images);
5 μm (magnifications).
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retrograde directions with a Vm of 1.1±0.3 µm s
−1 and 0.7
±0.1 µm s−1, respectively (n=8 neurons) (Table S2). We
determined that vesicles colabeled for TAG-1 and ADAM23
moved mostly retrogradely, as previously observed for TAG-1
(Pinatel et al., 2017). Therefore, ADAM23–mCherry was
preferentially transported anterogradely when expressed alone
(65±9% of displacements were anterograde; Table S1,
Fig. 6B,B′). In contrast, it moved mostly retrogradely when
associated with TAG-1 (only 34±6% of displacements were
anterograde; Table S2, Fig. S4B,D). The retrograde vesicles
labeled for TAG-1 and ADAM23 are likely endosomes and might
provide AIS enrichment at the steady-state by recycling the distal
axonal membrane. Next, we examined axonal transport in neurons
co-expressing ADAM23–mCherry and Caspr2–GFP (Fig. S4F–H,
Movie 7). Kymograph analysis of transport events indicated that
these vesicles moved in the anterograde and retrograde directions
with a velocity of 1.4 µm s−1 and 1 µm s−1, respectively (Fig. S4H).
In conclusion, the combinatorial expression of CAMs associated
with the Kv1 complex in hippocampal neurons may impact their
respective subcellular distribution along the axon. ADAM23 was
differentially distributed when co-expressed with TAG-1 or with
Caspr2, being either enriched at the AIS or homogenously
expressed all along the axon, respectively. Moreover, our data
indicate that these CAMs can be sorted together in axonally
transported vesicles in cultured hippocampal neurons.
DISCUSSION
In the present study, we analyzed the axonal targeting of CAMs
associated with Kv1 channels in cultured hippocampal neurons. We
showed that LGI1 is colocalized with ADAM22 at the AIS of
cultured hippocampal neurons. The human mutations LGI1S473L
and LGI1R474Q, which are associated with epilepsy, impair the
association with ADAM22 and the trapping of LGI1 at the AIS,
which is a possible pathogenic mechanism. The co-expression of
ADAM22 or ADAM23 strongly modulates the targeting of LGI1,
leading to a decrease at the AIS and an increase at the overall
neuronal cell surface. We demonstrated that association with
ADAM proteins is not only required for the anchoring of LGI1
at the cell surface, but is also implicated in its trafficking, including
ER exit, N-glycosylation processing and axonal vesicular transport.
In addition, an interplay was evidenced between ADAM proteins
and other CAMs of the Kv1 complex, namely, TAG-1 and Caspr2,
which may be implicated in their selective targeting at the AIS.
We observed that LGI1 transfected in cultured hippocampal
neurons is tethered at the AIS and colocalized with ADAM22 and
Kv1 channels. We also found that co-expression of LGI1 with
ADAM22 or ADAM23 strongly modulates the subcellular
distribution of LGI1. Co-transfection with ADAM proteins
strongly increases the surface expression of LGI1 at the somato-
dendritic and axonal compartments. As a consequence, the
enrichment of LGI1 at the AIS becomes reduced in neurons
overexpressing ADAM22 and ADAM23. Thus, the association of
LGI1 with the Kv1 channels at the AIS, along the axon or at the
synaptic terminals may be modulated depending on its association
with ADAM22 or ADAM23. ADAM22 is enriched at the AIS of
cultured hippocampal neurons and colocalized with Kv1 channels
and PSD93, but it is not required for the AIS clustering of Kv1.2 as
indicated by the phenotype of Adam22−/− mice (Ogawa et al.,
2010). However, reciprocally, high expression of ADAM22 or
ADAM23 may remove LGI1 associated in a complex with the Kv1
channels from the AIS towards the axonal terminals, through a
competition with ADAM22 tethered at the AIS. Indeed, loss-of-
function experiments using ADAM22-specific siRNAs indicate that
ADAM22 is critical for the trapping of LGI1 at the AIS.
LGI1 has been reported to act presynaptically as a negative
regulator of excitatory transmission in early postnatal stages,
possibly through Kv1-mediated modulation of synaptic release
(Boillot et al., 2016). More recently, LGI1 was shown to localize at
the AIS of CA3 hippocampal neurons, regulating action potential
firing by controlling the density of Kv1 channels (Seagar et al.,
2017). LGI1-knockout mice display a downregulation of the
expression of Kv1.1 and Kv1.2 via a post-translational
mechanism (Seagar et al., 2017), such as altered trafficking or
increased degradation, that may contribute to epileptogenesis.
Interestingly, here we show that the human missense mutations
LGI1S473L and LGI1R474Q, which are associated with epilepsy,
impair LGI1 trapping at the AIS in hippocampal neurons, which is
as a possible pathogenic mechanism. The LGI1R407C mutant is
properly recruited at the AIS indicating that another function of
LGI1 might be affected in this secretion mutant. However, recently,
this mutation was found in control individuals indicating that it
may not be pathogenic (Yamagata et al., 2018). Furthermore,
co-immunoprecipitation experiments indicate that the S473L and
R474Q mutations, but not the R407C mutation strongly decrease
the interaction with ADAM22 and not with ADAM23. Since
ADAM22 is specifically enriched at the AIS of cultured
hippocampal neurons, we hypothesize that altered binding with
ADAM22 may prevent trapping of LGI1 mutants at the AIS. In a
recent report, Yamagata et al. (2018), resolved the crystal structure
of the LGI1 in complex with ADAM22 and showed that the
R474Q mutation is located at the LGI1–LGI1 interface and does not
disrupt the cis-interaction with ADAM22, but does disrupt the
higher-order assembly of LGI1–ADAM22 heterotetramers. Thus,
homodimerization of LGI1 and its association in complex with
ADAM22 may be required for its concentration at the AIS.
The ADAM proteins may act either as chaperones promoting
LGI1 export or as anchors to stabilize the secreted LGI1 protein at
the neuronal cell surface, which are indeed two non-exclusive
processes. First, we demonstrated that LGI1 cell surface targeting is
strongly increased by its binding to ADAM22 or ADAM23 both
in HEK cells and in neurons. Second, a distinct carbohydrate
processing is observed when LGI1 is co-expressed with ADAM22
or ADAM23 in HEK cells with a doublet of Endo H-sensitive and
Endo H-resistant glycoforms, whereas an intermediate shift after
Endo H treatment is detected when LGI1 is expressed alone. These
results indicate that binding with ADAM proteins may induce a
conformational switch further enhancing the ER exit of LGI1. LGI1
may bear distinct carbohydrates when associated or not with
ADAMs, or when targeted to the synapses or to the AIS.
In addition, most of the missense mutations identified in ADLTE
were classified as secretion-defective mutations, indicating that this
genetic disorder could be a conformational disease (Yokoi et al.,
2015). The LGI1S473L mutant, which is secreted, was shown to
exhibit defective binding activity for ADAM22 in tandem affinity
purification using transgenic mouse brain (Yokoi et al., 2015). A
consequence of this reduced binding activity might be to interfere
with the optimal transport-permissive conformation of the mutant
protein. However, we show here that LGI1S473L may sufficiently
associate with both ADAM22 and ADAM23 to be properly
processed with Endo H-resistant N-glycans in HEK cells. In
contrast, this mutation does not allow the molecule to be enriched at
the AIS, indicating that LGI1 may require a higher-order association
with ADAM22 to be trapped specifically in this axonal subregion.
LGI1 is also known to interact with NgR1 (also known as RTN4R),
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which may enhance the association of LGI1 with ADAM22
(Thomas et al., 2016). Whether any mutation in LGI1 linked with
epilepsy may induce defects in NgR1 binding is unknown (Thomas
et al., 2016). ADAM11 is also known as a ligand for LGI1 (Sagane
et al., 2008) that plays a critical role in localizing the Kv1 channels at
the presynaptic terminals of cerebellar basket cells (Kole et al.,
2015). There is no indication that these ligands of LGI1 are
localized at the AIS. Thus, the pathogenic mechanisms for the
LGI1S473L and LGI1R474Q mutations may rely both on defective
binding to one of its receptors and to its mistargeting into the
different axonal subcompartments, including the AIS and synaptic
terminals.
LGI1 has been proposed to form a trans-synaptic bridge through
its binding with ADAM22 and ADAM23 expressed at the post- and
pre-synapse, respectively. ADAM22 and ADAM23 are partitioned
into synaptic fractions depending on LGI1 (Fukata et al., 2010).
LGI1 and ADAM22 bind PSD-95 and, consequently, may stabilize
the AMPAR and stargazin complex, regulating synaptic strength at
the excitatory synapse (Fukata et al., 2006). Interestingly, LGI1
seems to be required for the synaptic localization of ADAM22 and
ADAM23 as indicated by immunohistochemical and biochemical
analyses of LGI1-deficient mice (Fukata et al., 2010). Conversely,
in Adam22−/− and Adam23−/−mice, the neuropil staining of LGI1 is
lower in most hippocampal regions, indicating that the distribution
of these molecules at the synaptic neuropil is interdependent (Yokoi
et al., 2015). Our results show that LGI1 may associate with
ADAM22 or ADAM23 early along the secretory pathway at the ER
level to be sorted with either ADAM molecule in axonal transport
vesicles. We observed that vesicles containing ADAM22 and
ADAM23 either alone or colocalized with LGI1 are axonally
transported through the AIS, as reported for axonal cargoes
(Al-Bassam et al., 2012; Petersen et al., 2014). The vesicular
axonal transport of ADAM23 was predominantly oriented in the
anterograde direction, whereas ADAM22 was preferentially
transported in the retrograde direction. Such a differential
transport may promote a distinct pre- and post-synaptic
distribution at the steady state. Therefore, the interdependence of
LGI1 and ADAM proteins for their synaptic distribution may be
based on their association during axonal transport. As we observed
for LGI1 and ADAM proteins, the axonal transport of Kv1.2
subunits associated with the accessory Kvβ2 subunits has been
reported to occur both in the anterograde and retrograde directions
with similar velocities (Gu and Gu, 2010). The axonal vesicular
transport of Kv1.2 is facilitated by Kvβ2 and depends on the
kinesins KIF3A and KIF5B (Gu and Gu, 2010; Rivera et al., 2007).
Whether LGI1 and ADAM proteins can traffic together with Kv1
channels as a preformed complex and using identical molecular
motors deserves further investigations.
The composition of the Kv1 complex and the mechanisms
regulating its recruitment at the AIS are still elusive. The analysis of
the Caspr2 interactome in hippocampus indicates that this protein
associates with TAG-1 and Kv1, as well as with ADAM22 and
LGI1 (Chen et al., 2015). From co-immunoprecipitation
experiments of transfected HEK cells, we determined that Caspr2
interacts, through its extracellular or transmembrane domain, with
ADAM22 and ADAM23, whereas TAG-1 only precipitated with
ADAM22. Moreover, the ADAM proteins can be sorted together
with Caspr2 or TAG-1 in axonal transport vesicles. We recently
showed that TAG-1 is enriched at the AIS, whereas Caspr2 is
uniformly expressed along the axon of cultured hippocampal
neurons (Pinatel et al., 2017). Similarly, here we noticed that
ADAM23 is enriched at the AIS when co-transfected with TAG-1,
but not when co-transfected with Caspr2. Therefore, the ADAM
family may play a pivotal role for the interdependent distribution
of the different sets of CAMs associated with Kv1 at the AIS.
Our results indicate that a focus on AIS might be relevant for
the further dissection of the pathogenic mechanisms involving LGI1
in epilepsy.
MATERIALS AND METHODS
Constructs
The pCDNA3-Caspr2-HA construct encodes human Caspr2 with the HA
epitope inserted downstream of the signal peptide between the residues
Trp26 and Thr27 (Bel et al., 2009). The Caspr2–HA deleted construct
Caspr2Δcyt (stop codon at amino acid 1285) was as described previously
(Pinatel et al., 2015). NrCAM–GFP was previously described (Falk et al.,
2004). The human TAG-1–GFP and Caspr2–GFP constructs with GFP
downstream of the signal peptide were as described previously (Pinatel
et al., 2015). Caspr2–mCherry was generated by insertion into the EcoRI-
BamHI sites of pmCherry-N1. Plasmids encoding human LGI1, ADAM22
and ADAM23 were purchased from Origene. LGI1–GFP was generated by
insertion in pEGFP-N3 (Pinatel et al., 2015). The R407C, S473L and
R474Q missense mutations of LGI1–GFP were generated by using the
QuikChange II mutagenesis kit (Stratagene). ADAM22–mCherry and
ADAM23–mCherry were generated by insertion into the NheI-KpnI
sites of pmCherry-N1. PCR-amplified products were verified by
sequencing (Genewiz). Silencer select predesigned siRNAs were
purchased from Ambion, Thermo Fisher Scientific. Two different siRNAs
targeting rat ADAM22 were used with antisense sequences
5′-UGCGUUGAAAUUCAGAUGGaa-3′ in exon 6,7 (ref. s186484) and
5′-UGAGAUUAUACCGAUAUUGtg-3′ in exon 12 (ref. s186485).
The antisense sequence of the siRNA targeting rat ADAM23 was
5′-AUCGUUAACAAUCAUAAGCtc-3′ (ref. s153985) and the negative
control siRNA was a universal non-targeting sequence (ref. 4390843).
Western blotting and immunoprecipitation
HEK cells were co-transfected with Caspr2–HA, Caspr2Δcyt–HA, Caspr2–
GFP, LGI1–GFP, TAG-1–GFP or NrCAM–GFP, and ADAM22–mCherry
or ADAM23–mCherry. HEK cells were co-transfected with GFP-tagged
LGI1, LGIR407C, LGI1S473L and LGI1R474Q, and ADAM22–mCherry or
ADAM23–mCherry. Cells were lyzed for 30 min on ice with 50 mM Tris-
HCl pH 7.5, 1% NP-40, 10 mMMgCl2 and protease inhibitors, centrifuged
at 4°C for 15 min at 12,000 g. After preclearing for 1 h at 4°C with protein
G–Sepharose, supernatants were immunoprecipitated overnight at 4°C with
protein G–agarose coated with rabbit anti-mCherry (RFP) antibody (2 µl)
and mouse anti-GFP IgG (1 µg) or rat anti-HA IgG (1 µg). The beads were
washed twice with 50 mM Tris-HCl pH 7.4, 150 mM NaCl and 1% NP-40,
twice in 50 mM Tris-HCl, 150 mM NaCl and twice in 50 mM Tris-HCl.
Immunoprecipitates were analyzed by immunoblotting with anti-HA, anti-
GFP or anti-mCherry antibodies diluted 1:1000. Blots were developed using
the ECL chemiluminescent detection system (Roche). HEK cells were
transfected with GFP-tagged LGI1 or LGI1S473L alone or co-transfected
with ADAM22–mCherry or ADAM23–mCherry. The LGI1 proteins were
immunoprecipitated from the lysates using mouse anti-GFP, eluted
from protein G–Sepharose in 50 mM Tris-HCl pH 6, 0.2% SDS, 1%
β-mercaptoethanol, 0.5% Triton X-100, 1 mM EDTA and protease
inhibitors and incubated for 3 h with Endoglycanase H (3 mU/µl) or
PNGase F (1 U/µl) (Roche).
Antibodies and immunofluorescence staining
The chicken anti-MAP2 (ab5392) and the goat anti-GFP (ab 5450) antibody
were purchased from Abcam, the rat anti-HA mAb (clone 3F10) and the
mouse anti-GFP (cat. 11 814 460 001) from Roche, the rabbit anti-RFP
(anti-mCherry, code 600-401-379) antiserum from Rockland, the rabbit
anti-ADAM23 (cat PA5-30939) and the rabbit anti-synaptobrevin
(VAMP2) (cat OSS00035W) from ThermoScientific. The mouse anti-
ankyrinG (clone N106/36), anti-ADAM22 (clone N57/2 and N46/30) anti-
LGI1 (N283/7), anti-pan neurofascin (clone A12/18) and anti-Kv1.2 (clone
K14/16) mAbs were obtained from the UC Davis/NIH NeuroMab facility.
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The mouse anti-TAG-1 1C12 was a gift from Dr Domna Karagogeos
(IMBB-FORTH, University of Crete Medical School, Greece) and the
chicken anti-ADAM23 from Dr Dies Meijer (Center for Discovery Brain
Sciences, University of Edinburgh, UK). Alexa Fluor 488-, 568- and
647-conjugated secondary antibodies were obtained from Molecular
Probes. Immunostaining for Caspr2–HA, LGI1–GFP, TAG-1–GFP and
ADAM23 (rabbit antibody) was performed on live cells with antibodies
diluted 1:500 in culture medium for 30–60 min. Cells were fixed with 4%
paraformaldehyde in PBS for 10 min and permeabilized with 0.1% Triton
X-100 for 10 min. Immunofluorescence staining was performed using
chicken anti-MAP2 (1:10,000), mouse anti-ankyrinG (1:100), rabbit
anti-synaptobrevin (1:500), mouse anti-ADAM22 clone A46/30 (1:100)
or chicken anti-ADAM23 (1:1000) antibodies and with secondary
antibodies diluted in PBS containing 3% bovine serum albumin. After
washing in PBS, cells were mounted in Mowiol (Calbiochem). Since the
direct fluorescence of LGI1-GFP was very low after fixation with
paraformaldehyde, the detection of LGI1-GFP at the neuronal surface was
performed using live immunolabeling with anti-GFP antibody and either
Alexa Fluor 568 or Alexa Fluor 488 secondary antibody.
Cell culture
Cell culture media and reagents were from Invitrogen. HEK-293 cells recently
authenticated and tested for contamination were grown in DMEM containing
10% fetal calf serum and were transiently transfected using jet PEI (Polyplus
transfection, Ozyme). Primary hippocampal cell cultures were prepared from
embryonic day 18-Wistar rats. Hippocampi were collected in Hank’s
balanced salt solution, dissociated with trypsin and plated at a density of
1.2 105 cells/cm2 on poly-L-lysine coated coverslips. The hippocampal
neurons were cultured in Neurobasal supplemented with 2% B-27, 1%
penicillin-streptomycin and 0.3% glutamine in a humidified atmosphere
containing 5% CO2 at 37°C. Hippocampal neurons were transfected using
Lipofectamine 2000 (Thermo Fisher Scientific) with Caspr2–HA Caspr2–
GFP, TAG-1–GFP, LGI1–GFP, NrCAM–GFP, ADAM22–mCherry and
ADAM23–mCherry or co-transfected with two of these constructs at DIV7 or
DIV13 and immunostained 1 day later. For siRNA experiments, hippocampal
neurons were co-transfected at DIV7 using Lipofectamine 2000 with 1 µg
LGI1–GFP, 0.5 µg mCherry and 30 pM siRNA per 18 mm coverslips and
immunostained 4 days later. All animal experiments were carried out
according to the European and Institutional guidelines for the care and use
of laboratory animals and approved by the local authority (laboratory’s
agreement number D13-055-8, Préfecture des Bouches du Rhône).
Confocal microscopy and image analysis
Image acquisition was performed on a Zeiss laser-scanning microscope
LSM780 equipped with a 63×1.32 NA oil-immersion objective. Images of
GFP- or mCherry- or Alexa-Fluor-stained cells were obtained using the
488 nm band of an argon laser and the 568 nm and 647 nm bands of a solid-
state laser for excitation. Fluorescence images were collected automatically
with an average of two-frame scans. Quantitative image analysis was
performed using ImageJ on confocal sections (10–20 neurons in each
condition). The fluorescence intensity wasmeasured in two regions of interest
(ankyrinG-positive AIS and axon) using identical confocal parameters.
Regions corresponding to the AIS were manually selected on ankyrinG
images and reported on other channels for intensity measurements. All
intensities were corrected for background labeling using the Zen software
(Zeiss). Statistical analysis was performed using Statview or GraphPad Prism
software. The data was tested for a normal distribution by using a d’Agostino
and Pearson’s test. For multiple group comparisons, we used one-way
ANOVA followed by Fisher’s test. The non-parametric Mann–Whitney test
was used when the assumption of normality was not possible.
Imaging vesicle transport
Coverslips with neurons were loaded into a sealed heated chamber in
imaging medium (Hank’s balanced salt solution, pH 7.2, with 10 mM
HEPES and 0.6% glucose). Recordings were made 18 h after transfection.
The axons were selected on the basis of their much greater length by
comparison with dendrites. Live immunostaining using Alexa-Fluor-
647-conjugated NF186 was performed to visualize the AIS. Vesicle
transport was imaged using a Zeiss laser-scanning microscope equipped
with a 63×1.32 NA oil-immersion objective and 37°C heating chamber.
Dual-color recordings were acquired using simultaneous excitation with 488
nm (2–4%) and 561 nm lasers (1–2%), and GaSP photomultiplier tube
(PMT)1 for 499–551 and PMT2 for 569–735 detections (562×240 pixels,
average 2, open pinhole, 1.5 s scanning time, streamed time-lapse recording
during 3-9 min). Kymographs were generated using ImageJ software and
contrast inverted so that the fluorescent vesicles correspond to dark lines.
Overlapping transport events were analyzed and the velocity measured.
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Goutebroze, Christophe Leterrier, Bénédicte Dargent and Francis Castets for
helpful discussions and to Valérie Crépel for support and discussions. We thank the
University of California Davis/National Institutes of Health NeuroMab Facility.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: B.H., C.F.-S.; Investigation: B.H., L.M., K.A., C.F.-S.; Writing -
original draft: C.F.; Supervision: C.F.-S.; Funding acquisition: C.F.-S.
Funding
This work was supported by the Association pour la Recherche sur la Sclérose en
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Table S1. 
Kymograph analysis of anterograde and retrograde axonal transport of 
ADAM22-mCherry, ADAM23-mCherry in DIV8 hippocampal neurons 
Anterograde   Retrograde Behaviour$
Events  Total ∆x Vm Events  Total ∆x Vm 
(n) (µm) (%) (µm/s) (n)  (µm) (µm/s) 
ADAM22 
Neuron 1 0  -    (0) 7 20 0.34 retro 
Neuron 2 2  37 (7) 0.53 28 461 0.54 retro 
Neuron 3  1  16 (15) 1.20 9 87 0.29 retro 
Neuron 4 2  30 (31) 0.45 4 67 0.52 bidir 
Neuron 5 4  54 (39) 0.47 7 85 0.47 bidir 
Neuron 6 4  108 (51) 1.05 5 102 0.91 bidir 
Neuron 7 6  98 (55) 0.64 6 80 0.58 bidir 
Neuron 8 4  109 (59) 0.64 7 76 0.33 bidir 
Neuron 9  5  87 (63) 0.73 3 50 0.54 bidir 
Neuron 10 11 174 (70) 0.52 5 73 0.54 antero 
Mean (39±7.8) * 0.69±0.1 0.51±0.06 
ADAM23 
Neuron 1 2  13 (7) 0.50 7 169 0.66 retro 
Neuron 2 4  91 (43) 1.43 7 130 0.45 bidir 
Neuron 3 5  81 (55) 0.62 4 67 0.29 bidir 
Neuron 4 7  143 (57) 0.74 6 108 0.55 bidir 
Neuron 5 4  213 (72) 1.27 5 83 0.80 antero 
Neuron 6 5  148 (75) 1.29 3 48 0.39 antero 
Neuron 7 7  134 (89) 0.89 2 17 0.61 antero 
Neuron 8 6  224 (93) 1.09 2 16 0.30 antero 
Neuron 9 10 298 (96) 1.11 2 12 0.75 antero 
Mean (65.2±9.5) 0.99±0.11 0.53±0.06 
The vesicular transport was considered as predominantly oriented when the sum of displacements 
(Total ∆x) in one direction was more than 2/3 of the total displacements during the 7-10 min period of 
recording. $The behaviour was classified as retrograde (retro), anterograde (antero), or bidirectional 
(bidir). *significant difference (P=0.0012) by comparison with ADAM23 value using ANOVA and Fisher 
test. 
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
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Table S2. 
Kymograph analysis of anterograde and retrograde axonal transport of ADAM23-
mCherry/LGI1-GFP and ADAM23-mCherry/TAG-1-GFP in DIV8 hippocampal neurons 
Anterograde Retrograde Behaviour$
Events  Total ∆x Vm Events  Total ∆x Vm 
(n) (µm) (%) (µm/s) (n)  (µm) (µm/s) 
ADAM23 + LGI1 
Neuron 1 20 252 (65) 0.66 7 136 0.63 bidir 
Neuron 2 9 99 (68) 0.98 3 47 0.97 antero 
Neuron 3 5 115 (77) 1.05 33 0.93 antero 
Neuron 4 6 89 (86) 0.78 1 14 0.93 antero 
Mean (74±4.7) 0.87±0.09 0.86±0.08 
ADAM23 + TAG-1 
Neuron 1 2 28 (15) 0.89 7 159 0.65 retro 
Neuron 2 3 24 (18) 0.46 6 112 0.85 retro 
Neuron 3 3 36 (20) 1.62 13 148 0.53 retro 
Neuron 4 3 31 (22) 0.5 18 108 0.3 retro 
Neuron 5 3 80 (30) 2.9 11 190 1.14 retro 
Neuron 6 6 97 (42) 0.9 9 136 0.77 bidir 
Neuron 7 8 143 (60) 0.9 6 95 0.75 bidir 
Neuron 8 9 150 (63) 0.66 3 86 0.39 bidir 
Mean (33.7±6.4)* 1.1±0.27 0.67±0.09 
The vesicular transport was considered as predominantly oriented when the sum of displacements 
(Total ∆x) in one direction was more than 2/3 of the total displacements during the 7-10 min period of 
recording. $The behaviour was classified as retrograde (retro), anterograde (antero), or bidirectional 
(bidir). *significant difference (p=0.0114) by comparison with ADAM23 value using ANOVA and Fisher 
test. 
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
LGI1    LGI1        A23m
alone (+A23m)    (+LGI1)
D
*
0
1
2
3
4
AIS/axon
M
ea
n
flu
or
es
ce
nc
e 
int
en
sit
y
ra
tio
* *
surface LGI1-GFP ADAM23-mChC
C’
C’’
surface LGI1-GFP
ADAM23-mCh
AnkG
surface ADAM23
ADAM23-mCh
AnkG
surface ADAM23
DIV8
DIV8
B
C’’
surface LGI1
LGI1-GFP
DIV8
A surface LGI1
Figure S1. LGI1-GFP associated with ADAM23 becomes non-polarized in cultured hippocampal neurons Hippocampal 
neurons were transfected at DIV8 with LGI1-GFP (A), ADAM23-mCherry (B) or co-transfected with both molecules (C).
Neurons were surface labeled using anti-GFP (A, red; C, green), or anti-ADAM23 (B, green) antibodies, fixed and permeabilized
before immunostaining for AnkyrinG (blue) (arrowheads). The fluorescence for ADAM23-mCherry was directly imaged (B, C,
red). Note that LGI1-GFP surface labeling is highly restricted to the AIS (A) whereas ADAM23-mCherry surface expression is
not polarized (B). (C) Co-transfection with ADAM23-mCherry strongly enhances LGI1-GFP expression at the somato-
dendritic and axonal surface. Insets show punctate colocalization of LGI1-GFP and ADAM23-mCherry along neurites (arrows
in C’). Note that LGI1-GFP is not anymore enriched at the AIS (C”). (D) Ratios of fluorescence intensity between AIS and
axon in neurons transfected at DIV8 with LGI1-GFP alone or co-transfected with ADAM23-mCherry (A23m). *indicates
significant differences by comparison with LGI1-GFP transfected alone (F(2, 29)=29.17, ANOVA and p<0.01, Fisher test). Bar:
A-C, 20 µm, in inset: 5 µm.
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Figure S3. ADAM23 co-localized with TAG-1-GFP at the AIS of hippocampal neurons Hippocampal neurons were 
co-transfected at DIV14 with TAG-1-GFP and ADAM23 (A), or with Caspr2-HA and ADAM23 (B, C). Neurons
were surface labeled with mouse anti-GFP mAb (A, green) or rat anti-HA (B, green) and rabbit anti-ADAM23
antibodies (red). Cells were fixed and permeabilized before immunostaining for AnkyrinG (blue, arrowheads). (A)
Note that ADAM23 was targeted and colocalized with TAG-1 at the AIS (inset). (B) In contrast, ADAM23 was
faintly detected along the axon when co-transfected with Caspr2-HA. (C) Immunoendocytosis of Caspr2 was induced
using anti-HA mAb and anti-rat Alexa488 antibodies (green) during 1 h at 37 °C. After fixation and
permeabilization, neurons were stained using chick anti-ADAM23 (blue) and rabbit anti-EEA1 (red) as a maker of early
endosomes. Note that in dendrites, ADAM23 was co-internalized with Caspr2 in intracellular vesicles indicated with
arrows. Bar in A-C, 20 µm, in inset, 5 µm.
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
ADAM23
70 µm
4’30
TAG1
7’30
70 µm
60 µm
ADAM23
TAG1
TAG1/ADAM23
TAG-1-GFP
ADAM23-mcherry
D
TAG1/ADAM23
A
A’
B C
A23 TAG1
E
t 0
t  4.5 s
t 12 s
210 s
Caspr2
87 µm
Caspr2-GFP
ADAM23-mcherry
t0 3 s 21 s 25 s
F
HG
Caspr2-GFP/ADAM23-mCherry
ADAM23
Figure S4. ADAM23-mCherry can be sorted with TAG-1-GFP or Caspr2-GFP within the same axonal transport vesicles (A-E) Neurons co-
transfected at DIV8 with TAG-1-GFP and ADAM23-mCherry. Stream time-lapse images of transport vesicles were acquired at 1 frame per 1.5 s
in proximal (A, A’) and distal (C) axonal regions. (B, D) The corresponding kymographs showed overlapping trajectories of vesicles labeled
for TAG-1-GFP and ADAM23-mCherry. The horizontal arrow indicates the distance along neurite and orientation. The orange arrowhead
indicates the position of the axonal bifurcation (A’, B). (E) Example of a sequence showing a moving co-labeled vesicle. The vesicles moved
mostly in the retrograde direction. Movies 5 and 6 show time-lapse recording of these axons. (G-H) Hippocampal neuron transfected at DIV8
with Caspr2-GFP and ADAM23-mCherry. Stream time-lapse images of axonal transport vesicles were acquired at 1 frame per 1.5 s for 210 s in
the region shown in the inset in G. (F) Time-lapse sequence showing a moving vesicle that contains both Caspr2-GFP and ADAM23-
mCherry. (H) Corresponding kymographs showing overlapping trajectories of vesicles labeled for Caspr2-GFP and ADAM23-mCherry. Movie 7
shows time-lapse recording of this axon.
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
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Movie 2. Axonal transport of ADAM23-mCherry vesicles
Hippocampal neuron transfected with ADAM23-mCherry at DIV8. Vesicle transport visualized 16 h after
transfection. Streamed time-lapse images were acquired with 40 frames per 60 s for 200 s. Movie is
played at 5.3 frames per second. Note that ADAM23-mCherry vesicles moved mostly in the anterograde
direction (9 vesicles), only one vesicle is moving retrogradely.
Movie 1. Axonal transport of ADAM22-mCherry vesicles
Hippocampal neuron transfected with ADAM22-mCherry at DIV8. Vesicle transport visualized 16 h after
transfection. Streamed time-lapse images were acquired with 40 frames per 60 s for 96 s. Movie is played at
5.3 frames per second. Note that two vesicles moved in the retrograde and one in the anterograde direction.
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
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Movie 4. Transport of vesicles colabeled with LGI1-GFP and ADAM23-mCherry in a distal axon
A neuron co-transfected with LGI1-GFP and ADAM23-mCherry at DIV8. Vesicle transport visualized 16 h after
transfection using two-channel overlay recording. Streamed time-lapse images were acquired with 40 frames per 60 s
for 80 s. Movie is played at 5.3 frames per second. Note the bidirectional transport of double-labeled vesicles arriving
to and starting from the growth cone.
Movie 3. Transport of vesicles colabeled with LGI1-GFP and ADAM23-mCherry in a proximal axon
A neuron co-transfected with LGI1-GFP and ADAM23-mCherry at DIV8. Vesicle transport visualized 16 h after
transfection using two-channel overlay recording. Streamed time-lapse images were acquired with 40 frames per 60 s for
90 s. Movie is played at 5.3 frames per second. Note the bidirectional transport of double-labeled vesicles.
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
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Movie 6. Transport of vesicles colabeled with TAG-1-GFP and ADAM23-mCherry in the distal axonal region
A neuron co-transfected at DIV8 with TAG-1-GFP and ADAM23-mCherry. Axonal transport visualized 16 h after transfection
using two-channel overlay recording. Streamed time-lapse images were acquired with 40 frames per 60 s for 116 s. Movie is
played at 5.3 frames per second. Note the bidirectional transport of the double-labeled vesicles.
Movie 5. Transport of vesicles colabeled with TAG-1-GFP and ADAM23-mCherry in the proximal axonal region
A neuron co-transfected at DIV8 with TAG-1-GFP and ADAM23-mCherry. Axonal transport visualized 16 h after transfection
using two-channel overlay recording. Streamed time-lapse images were acquired with 40 frames per 60 s for 132 s. Movie is
played at 5.3 frames per second. Note that double-labeled vesicles moved mostly retrogradely.
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
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Movie 7. Axonal transport vesicles containing Caspr2-GFP and ADAM23-mcherry
A neuron co-transfected at DIV8 with Caspr2-GFP and ADAM23-mCherry. Axonal transport visualized
16h after transfection using two-channel overlay recording. Streamed time-lapse images were acquired
with 40 frames per 60 s for 210 s. Movie is played at 5.3 frames per second. In this axon, five double-
labeled vesicles are observed moving in the retrograde direction.
J. Cell Sci.: doi:10.1242/jcs.219774: Supplementary information
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